Pfizer Animal Health acquires two market-leading livestock genomics companies.

Pfizer Animal Health acquires two market-leading livestock genomics companies:

* Catapult Genetics, Pty., Ltd., focused on developing and commercializing innovative livestock DNA tests and gene markers to assist global food producers, processors and retailers in improving profitability and quality in the global food chain; and

* Bovigen, LLC, which markets DNA technology, including Catapult's products in the U.S. and throughout Canada, Central America and South America.

"This is a strategic initiative that places Pfizer at the forefront of livestock gene marker R&D and enhances Pfizer's ability to offer more complete solutions to global livestock producers," says Pfizer Animal Health Pres. Juan Ramon Alaix.